Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply
Friday, August 13, 2021Artiva Biotherapeutics Inc an oncology company focused on developing and commercializing primary allogeneic natural killer NK cell therapies to treat cancer today announced the expansion of the Companys US facilities in San Diego The new squarefoot f...
Nimbus Therapeutics and Schrödinger Extend Longstanding Collaboration to Discover Novel Therapeutics for Select Targets
Friday, August 13, 2021Nimbus Therapeutics a biotechnology company designing breakthrough medicines through structurebased drug discovery and development today announced the extension of its collaboration with Schrdinger Inc to discover and design small molecule therapeuti...
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma
Thursday, August 12, 2021C Therapeutics Inc CT a clinicalstage biopharmaceutical company pioneering a new class of smallmolecule medicines that selectively destroy diseasecausing proteins through degradation today announced that the US Food and Drug Administration FDA has gr...
Ceapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, Avenanthramide
Thursday, August 12, 2021Ceapro Inc a growthstage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries announced today that it has entered into a research agreement for a Phase safety and pharmac...
Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada
Wednesday, August 11, 2021Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced a Memorandum of Understanding MoU with the government of Canada to build a stateoftheart messenger RNA mRNA vaccine manufacturing facility in...
Vensica Therapeutics Inks Strategic Partnership with Merz
Wednesday, August 11, 2021Vensica Therapeutics a clinical stage biopharmaceutical company announced that it has signed a strategic collaboration agreement with Merz Therapeutics a business of the Merz Group and a leader in the field of neurotoxins Vensica has licensed Merzs b...
Dalrada Health and Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture
Tuesday, August 10, 2021To address the ongoing demand for COVID testing and to catalyze safe return of the workforce Dalrada Corporation is excited to announce that its subsidiary Dalrada Health entered into a joint venture partnership with Vivera Pharmaceutical Inc Vivera...
Fulgent Genetics Announces Acquisition of CSI Laboratories
Tuesday, August 10, 2021Fulgent Genetics Inc a technologybased genetic testing company focused on transforming patient care in oncology infectious and rare diseases and reproductive health today announced that it has acquired CSI Laboratories CSI to expand its presence in s...
Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China
Monday, August 09, 2021Epizyme Inc a fully integrated commercialstage biopharmaceutical company developing and delivering novel epigenetic therapies and HUTCHMED China Limited today announce a collaboration to research develop manufacture and commercialize TAZVERIK in Grea...
Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer
Friday, August 06, 2021Kite a Gilead Company and Appia Bio Inc an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells HSCs for cancer patients today announced a collaboration and license agreement to research and...
